<?xml version="1.0" encoding="UTF-8"?>
<ref id="B124">
 <label>124.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Petsch</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Schnee</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>AB</given-names>
   </name>
   <name>
    <surname>Lange</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Hoffmann</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Voss</surname>
    <given-names>D</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Protective efficacy of 
   <italic>in vitro</italic> synthesized, specific mRNA vaccines against influenza A virus infection
  </article-title>. 
  <source>Nat Biotechnol.</source> (
  <year>2012</year>) 
  <volume>30</volume>:
  <fpage>1210</fpage>â€“
  <lpage>6</lpage>. 
  <pub-id pub-id-type="doi">10.1038/nbt.2436</pub-id>
  <?supplied-pmid 23159882?>
  <pub-id pub-id-type="pmid">23159882</pub-id>
 </mixed-citation>
</ref>
